LoginSignup
PFI

Pfizer

Stock
Stock
ISIN: INE182A01018
Ticker: PFIZER
INE182A01018
PFIZER

Price

Price

Historical dividends and forecast

All dividend data

Pfizer has so far distributed 0.417 in 2024. The next dividend will be paid on 05.09.2025

0.94

CHART BY

Frequently asked questions

What is Pfizer's market capitalization?

The market capitalization of Pfizer is $2.83B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Pfizer's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Pfizer is 38.69. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Pfizer?

Pfizer's Earnings Per Share (EPS) over the trailing twelve months (TTM) is 1.601. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Pfizer's stock?

Currently, 3 analysts cover Pfizer's stock, with a consensus target price of $56.09. Analyst ratings provide insights into the stock's expected performance.

What is Pfizer's revenue over the trailing twelve months?

Over the trailing twelve months, Pfizer reported a revenue of $265.28M.

What is the EBITDA for Pfizer?

Pfizer's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $84.00M. EBITDA measures the company's overall financial performance.

What is the 5-year beta of Pfizer's stock?

The 5-year beta for Pfizer is 0.44. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Pfizer have, and what sector and industry does it belong to?

Pfizer employs approximately 1,721 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Pfizer's shares?

The free float of Pfizer is 15.14M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $2.83B

5Y beta

 0.44

EPS (TTM)

 1.601

Free Float

 15.14M

P/E ratio (TTM)

 38.69

Revenue (TTM)

 $265.28M

EBITDA (TTM)

 $84.00M

Analyst Ratings

The price target is $56.09 and the stock is covered by 3 analysts.

Buy

2

Hold

1

Sell

0

Information

Pfizer Limited is an India-based multinational pharmaceutical company. The Company focuses on therapy in four business categories, namely, Vaccines, Hospitals, Internal Medicine and Inflammation and Immunology. Pfizer’s Vaccines Division focuses on Prevenar 13, a Pneumococcal Conjugate Vaccine approved for administering to individuals of all ages against pneumococcal disease, an infection caused by streptococcus pneumoniae bacteria. The internal Medicine portfolio includes 17 specialties and seven therapy areas including respiratory, multivitamin and multimineral, gastrointestinal, pain, neuroscience, cardiovascular and women’s healthcare. Pfizer Hospital Business Unit focuses on providing advanced anti-infectives to institutions such as hospitals and nursing homes. Inflammation and Immunology focuses on discovering and developing novel therapeutics for chronic autoimmune diseases. Its brands include Prevenar13, CorexDX, Dolonex, Enbrel, Becosules and Folvite, among others.

1,721

Biotechnology & Drugs

Health Care

Identifier

ISIN

INE182A01018

Primary Ticker

PFIZER

Knockouts

Join the conversation
Sign upLogin